舒尼替尼间歇给药用于转移性肾细胞癌 - Suppr

Suppr

超能文献

Intermittent sunitinib for metastatic renal cell carcinoma.

作者信息

Venkatesan Priya

出版信息

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

DOI:10.1016/S1470-2045(17)30082-7

PMID:28163004

Abstract

摘要

相似文献

Intermittent sunitinib for metastatic renal cell carcinoma.

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

[News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].

Tumori. 2007 Sep-Oct;93(5):Suppl 1-16.

Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2012 Dec;10(4):277-9. doi: 10.1016/j.clgc.2012.04.005. Epub 2012 Jun 1.

Phase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2006 Jun;5(1):23-5. doi: 10.1016/s1558-7673(11)70151-3.

Sunitinib for metastatic renal cell carcinoma.

Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94.

Long-term response with sunitinib for metastatic renal cell carcinoma.

Urology. 2006 Sep;68(3):672.e19-20. doi: 10.1016/j.urology.2006.03.042. Epub 2006 Sep 18.

Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.

J BUON. 2010 Oct-Dec;15(4):798-9.

[Use of sunitinib in metastatic renal cell carcinoma patients with poor prognosis].

Vopr Onkol. 2011;57(1):50-4.

Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.

Am J Med Sci. 2010 Jun;339(6):580-1. doi: 10.1097/MAJ.0b013e3181dd1aa5.

Second-line treatment for renal cell cancer.

Br J Cancer. 2012 Feb 14;106(4):617-8. doi: 10.1038/bjc.2011.611.

引用本文的文献

Inhibiting stanniocalcin 2 reduces sunitinib resistance of Caki-1 renal cancer cells under hypoxia condition.

Ann Med Surg (Lond). 2023 Nov 1;85(12):5963-5971. doi: 10.1097/MS9.0000000000001450. eCollection 2023 Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Intermittent sunitinib for metastatic renal cell carcinoma.

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

[News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors].

Tumori. 2007 Sep-Oct;93(5):Suppl 1-16.

Dose matters: the importance of appropriate dosing: a case report on sunitinib treatment in a patient with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2012 Dec;10(4):277-9. doi: 10.1016/j.clgc.2012.04.005. Epub 2012 Jun 1.

Phase III study of sunitinib malate (SU11248) versus interferon-alpha as first-line treatment in patients with metastatic renal cell carcinoma.

Clin Genitourin Cancer. 2006 Jun;5(1):23-5. doi: 10.1016/s1558-7673(11)70151-3.

Sunitinib for metastatic renal cell carcinoma.

Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94.

Long-term response with sunitinib for metastatic renal cell carcinoma.

Urology. 2006 Sep;68(3):672.e19-20. doi: 10.1016/j.urology.2006.03.042. Epub 2006 Sep 18.

Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.

J BUON. 2010 Oct-Dec;15(4):798-9.

[Use of sunitinib in metastatic renal cell carcinoma patients with poor prognosis].

Vopr Onkol. 2011;57(1):50-4.

Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.

Am J Med Sci. 2010 Jun;339(6):580-1. doi: 10.1097/MAJ.0b013e3181dd1aa5.

Second-line treatment for renal cell cancer.

Br J Cancer. 2012 Feb 14;106(4):617-8. doi: 10.1038/bjc.2011.611.

引用本文的文献

Inhibiting stanniocalcin 2 reduces sunitinib resistance of Caki-1 renal cancer cells under hypoxia condition.

Ann Med Surg (Lond). 2023 Nov 1;85(12):5963-5971. doi: 10.1097/MS9.0000000000001450. eCollection 2023 Dec.

Intermittent sunitinib for metastatic renal cell carcinoma.

作者信息

Venkatesan Priya

出版信息

Lancet Oncol. 2017 Mar;18(3):e139. doi: 10.1016/S1470-2045(17)30082-7. Epub 2017 Feb 3.

DOI:10.1016/S1470-2045(17)30082-7

PMID:28163004

Abstract

摘要